WHO cautions on coronavirus 'immunity passports'

By LabPulse.com staff writers

April 27, 2020 -- The World Health Organization (WHO) has published a report expressing caution about the value of antibody tests for the novel coronavirus and stating that evidence for immunity after exposure is lacking.

The organization expressed its views on antibody testing in a scientific brief published on April 24. It noted that some governments are looking to use antibody tests to prove immunity, so-called 'immunity passports,' enabling citizens to return to work and for economies to reopen. However, there is no evidence that people who have recovered from COVID-19 and have antibodies are protected from getting infected a second time, the WHO stated. Studies indicate that people do have antibodies after recovering from infection, but some "have very low levels of neutralizing antibodies in their blood, suggesting that cellular immunity may also be critical for recovery."

"As of 24 April 2020, no study has evaluated whether the presence of antibodies to SARS-CoV-2 confers immunity to subsequent infection by this virus in humans," WHO wrote.

The WHO also flagged risks associated with inaccurate antibody tests, including false negatives and false positives, both of which have serious consequences, and raised questions about whether the tests can discriminate between antibodies to different kinds of coronaviruses. On Twitter, the organization clarified that it expects most people who are infected with COVID-19 will develop an antibody response that provides some level of protection, but the level and length of time of that protection is unknown.

As of April 26, more than 2.9 million cases had been confirmed worldwide, with more than 190,000 deaths, according to the WHO's latest situation report on the novel coronavirus.

WHO steps on the gas for collaboration on treatments and tests
The World Health Organization (WHO) announced on April 24 that it is coordinating a global trial to assess the safety and efficacy of four treatments...
WHO selects Roche, Primerdesign coronavirus tests for emergency use
Molecular tests by Primerdesign and Roche are the first two to get emergency use listing by the World Health Organization (WHO) for SARS-CoV-2, paving...
FDA vows action on false claims for coronavirus antibody tests
The U.S. Food and Drug Administration (FDA) is planning to take action against companies that are making false claims about serological tests for SARS-CoV-2/COVID-19...
Can the reality of coronavirus antibody tests live up to hype?
It's easy to see the appeal a rapid antibody test for the novel coronavirus would have in the imagination of the general public. Results come in a matter...
WHO updates guidance on coronavirus testing
The World Health Organization (WHO) has updated its recommendations on laboratory testing strategy for COVID-19. The strategy provides guidance on operating...

Copyright © 2020 LabPulse.com

Last Updated np 4/27/2020 1:36:44 PM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current